Cygnal (Drug Discovery) is Drug Discovery in United States that focus on regenerative processes business. Founded in 2017. They cover business area such as operator, drug, exonerate biology, cancer, novel therapeutic, immunological disease, regenerative process, client, exonerate treatment, various sort.
2017
( 7 years old in 2024 )
Regenerative Processes
-
325 Vassar Street
Suite 2B
Cambridge, MA 02139
United States
Private
operatordrugexonerate biologycancernovel therapeuticimmunological diseaseregenerative processclientexonerate treatmentvarious sort
* We use standard office opening hours in near Cygnal (Drug Discovery)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cygnal (Drug Discovery) is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Cygnal (Drug Discovery) business is focusing on Regenerative Processes.
Cygnal (Drug Discovery) headquarter office and corporate office address is located in 325 Vassar Street Suite 2B Cambridge, MA 02139 United States.
Cygnal (Drug Discovery) was founded in United States.
In 2024, Cygnal (Drug Discovery) is currently focus on regenerative processes sector.
Above is snippet of Google Trends for "regenerative processes" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cygnal (Drug Discovery), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
